These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 8539325)

  • 21. Naltrindole, an opioid delta receptor antagonist, blocks cocaine-induced facilitation of responding for rewarding brain stimulation.
    Reid LD; Hubbell CL; Glaccum MB; Bilsky EJ; Portoghese PS; Porreca F
    Life Sci; 1993; 52(9):PL67-71. PubMed ID: 8382329
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A non-rewarding, non-aversive buprenorphine/naltrexone combination attenuates drug-primed reinstatement to cocaine and morphine in rats in a conditioned place preference paradigm.
    Cordery SF; Taverner A; Ridzwan IE; Guy RH; Delgado-Charro MB; Husbands SM; Bailey CP
    Addict Biol; 2014 Jul; 19(4):575-86. PubMed ID: 23240906
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antitussive effects of naltrindole, a selective delta-opioid receptor antagonist, in mice and rats.
    Kamei J; Iwamoto Y; Suzuki T; Misawa M; Nagase H; Kasuya Y
    Eur J Pharmacol; 1993 Nov; 249(2):161-5. PubMed ID: 8287897
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Involvement of μ- and δ-opioid receptor function in the rewarding effect of (±)-pentazocine.
    Mori T; Itoh T; Yoshizawa K; Ise Y; Mizuo K; Saeki T; Komiya S; Masukawa D; Shibasaki M; Suzuki T
    Addict Biol; 2015 Jul; 20(4):724-32. PubMed ID: 25065832
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of mu, but not delta or kappa, opioid receptors in context-induced reinstatement of oxycodone seeking.
    Bossert JM; Hoots JK; Fredriksson I; Adhikary S; Zhang M; Venniro M; Shaham Y
    Eur J Neurosci; 2019 Aug; 50(3):2075-2085. PubMed ID: 29779230
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Opioid interactions in rhesus monkeys: effects of delta + mu and delta + kappa agonists on schedule-controlled responding and thermal nociception.
    Stevenson GW; Folk JE; Linsenmayer DC; Rice KC; Negus SS
    J Pharmacol Exp Ther; 2003 Dec; 307(3):1054-64. PubMed ID: 14557380
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antagonism of delta(2)-opioid receptors by naltrindole-5'-isothiocyanate attenuates heroin self-administration but not antinociception in rats.
    Martin TJ; Kim SA; Cannon DG; Sizemore GM; Bian D; Porreca F; Smith JE
    J Pharmacol Exp Ther; 2000 Sep; 294(3):975-82. PubMed ID: 10945849
    [TBL] [Abstract][Full Text] [Related]  

  • 28. kappa-Opioid receptor agonists prevent sensitization to the conditioned rewarding effects of cocaine.
    Shippenberg TS; LeFevour A; Heidbreder C
    J Pharmacol Exp Ther; 1996 Feb; 276(2):545-54. PubMed ID: 8632320
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Involvement of opioid mu 1 receptors in morphine-induced conditioned place preference in rats.
    Piepponen TP; Kivastik T; Katajamäki J; Zharkovsky A; Ahtee L
    Pharmacol Biochem Behav; 1997 Sep; 58(1):275-9. PubMed ID: 9264103
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Different roles of mu-, delta- and kappa-opioid receptors in ethanol-associated place preference in rats exposed to conditioned fear stress.
    Matsuzawa S; Suzuki T; Misawa M; Nagase H
    Eur J Pharmacol; 1999 Feb; 368(1):9-16. PubMed ID: 10096764
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Blockade of ventral pallidal opioid receptors induces a conditioned place aversion and attenuates acquisition of cocaine place preference in the rat.
    Skoubis PD; Maidment NT
    Neuroscience; 2003; 119(1):241-9. PubMed ID: 12763085
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Roles of opioid receptor subtypes in mediating alcohol-seeking induced by discrete cues and context.
    Marinelli PW; Funk D; Harding S; Li Z; Juzytsch W; Lê AD
    Eur J Neurosci; 2009 Aug; 30(4):671-8. PubMed ID: 19686472
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of the kappa opioid agonist R-84760 on cocaine-induced increases in striatal dopamine levels and cocaine-induced place preference in C57BL/6J mice.
    Zhang Y; Butelman ER; Schlussman SD; Ho A; Kreek MJ
    Psychopharmacology (Berl); 2004 Apr; 173(1-2):146-52. PubMed ID: 14712342
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of multiple opioid receptors in the potentiation of reward by food restriction.
    Carr KD; Papadouka V
    Brain Res; 1994 Mar; 639(2):253-60. PubMed ID: 8205479
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Naltrexone attenuation of conditioned but not primary reinforcement of nicotine in rats.
    Liu X; Palmatier MI; Caggiula AR; Sved AF; Donny EC; Gharib M; Booth S
    Psychopharmacology (Berl); 2009 Mar; 202(4):589-98. PubMed ID: 18807246
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Attenuation of the discriminative stimulus properties of cocaine by delta-opioid receptor antagonists.
    Suzuki T; Mori T; Funada M; Misawa M; Nagase H
    Eur J Pharmacol; 1994 Sep; 263(1-2):207-11. PubMed ID: 7821355
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of selective blockade of mu(1) or delta opioid receptors on reinstatement of alcohol-seeking behavior by drug-associated stimuli in rats.
    Ciccocioppo R; Martin-Fardon R; Weiss F
    Neuropsychopharmacology; 2002 Sep; 27(3):391-9. PubMed ID: 12225696
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of SNC 80 and naltrindole within a conditioned taste aversion design.
    Hutchinson AC; Simpson GR; Randall JF; Zhang X; Calderon SN; Rice KC; Riley AL
    Pharmacol Biochem Behav; 2000 Aug; 66(4):779-87. PubMed ID: 10973516
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dopamine, but not glutamate, receptor blockade in the basolateral amygdala attenuates conditioned reward in a rat model of relapse to cocaine-seeking behavior.
    See RE; Kruzich PJ; Grimm JW
    Psychopharmacology (Berl); 2001 Mar; 154(3):301-10. PubMed ID: 11351937
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Kappa opioid antagonist effects of the novel kappa antagonist 5'-guanidinonaltrindole (GNTI) in an assay of schedule-controlled behavior in rhesus monkeys.
    Negus SS; Mello NK; Linsenmayer DC; Jones RM; Portoghese PS
    Psychopharmacology (Berl); 2002 Oct; 163(3-4):412-9. PubMed ID: 12373442
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.